Whole-genome characterization of a colistin-resistant Klebsiella quasipneumoniae subsp. quasipneumoniae isolate from a urinary tract infection in Peshawar, Pakistan
Abstract
Klebsiella quasipneumoniae is a Gram-negative, non-motile, capsulated, facultative anaerobic rod within the K. pneumoniae species complex (KpSC) and is increasingly recognized as an opportunistic pathogen associated with bloodstream infections, urinary tract infections (UTIs), and other clinically significant conditions. Because it shares many phenotypic characteristics with K. pneumoniae, accurate diagnosis remains challenging in routine clinical settings, particularly in low-resource laboratories lacking access to molecular identification tools. In this study, we characterized the antimicrobial resistance (AMR) profile of a K. quasipneumoniae subsp. quasipneumoniae isolate obtained from a UTI case in Peshawar, Pakistan. The isolate exhibited a multidrug resistant (MDR) phenotype, with resistance to β-lactams, carbapenems, fluoroquinolones, and colistin (MIC 4 µg/mL), while remaining susceptible to aminoglycosides (amikacin and gentamicin) and tigecycline (MIC 2 µg/mL). Whole-genome sequencing (WGS) identified chromosomally encoded AMR determinants, including blaOKP-A-8, oqxAB, and fosA6, with no identifiable plasmid replicons detected. Multiple nonsynonymous mutations were observed in mgrB, pmrA/B, phoP/Q, lpxM, ompK35/36, and gyrA/parC, which have been previously associated with resistance phenotypes; however, their functional contribution in this isolate was inferred from genomic data and not experimentally validated. Virulence-associated loci such as fim, ecp, entB, and…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.